PP
AZN icon

Pingora Partners’s AstraZeneca AZN Stock Holding History

Pingora Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.7K Hold
125
– – 0.01% 162
2025
Q4 		$23K Hold
125
– – 0.01% 160
2025
Q3 		$19.2K Hold
125
– – 0.01% 164
2025
Q2 		$17.5K Hold
125
– – 0.01% 166
2025
Q1 		$18.4K Hold
125
– – 0.01% 167
2024
Q4 		$16.4K Hold
125
– – 0.01% 181
2024
Q3 		$19.5K Hold
125
– – 0.01% 176
2024
Q2 		$19.5K Hold
125
– – 0.01% 173
2024
Q1 		$16.9K Hold
125
– – 0.01% 193
2023
Q4 		$16.8K Buy
+125
New +$16.3K 0.01% 137

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Pingora Partners's AZN Position: Q1 2026 in Review

Pingora Partners held its AstraZeneca (AZN) position steady in Q1 2026 at 125 shares worth $24.7K. The position accounts for 0.01% of the portfolio, ranked #162.

Pingora Partners first reported a position in AZN in Q4 2023 and has held it in 10 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Pingora Partners held 125 shares of AstraZeneca worth $24.7K as of Q1 2026.
  • Pingora Partners left its AstraZeneca share count unchanged in Q1 2026.
  • AstraZeneca made up 0.01% of Pingora Partners's portfolio in Q1 2026, its #162 holding.
  • Pingora Partners first reported a position in AstraZeneca in Q4 2023 and has held it in 10 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Pingora Partners's 13F filing for Q1 2026, filed 15 May 2026.